1
[LETTERHEAD OF ONCOGENE SCIENCE]
EXHIBIT 10 (g)(v)
January 21, 1997
Dr. Xxxx Xxxxxxxx
Calbiochem-Novabiochem Corporation
00 Xxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
RE: TRADEMARK LICENSE AGREEMENT
Dear Xx. Xxxxxxxx:
Currently, your company has the right to use several trademarks owned
by Oncogene Science, Inc., including the mark "Oncogene Research Products" (the
"ORP Mark"), pursuant to the Trademark License Agreement between you and us
dated August 2, 1995 (the "Agreement"). The Agreement expires on August 2,
1998, and you have requested the right to continue using the ORP Mark beyond
the expiration date.
By this letter, we agree to extend your company's right to use the ORP
Mark, only, for an additional period of twelve (12) years, through August 1,
2010. You agree to comply with your obligations under the agreement, which will
remain in full force and effect for the ORP Mark until the end of this
extension period. This extension does not apply to any other trademark. If you
agree to these terms, please sign and date the enclosed copy of this letter in
the space provided below and return it to me. Thank you.
Sincerely,
/s/ XXXXXX X. XXXXXX
-------------------------------------
ONCOGENE SCIENCE, INC.
Xxxxxx X. Xxxxxx, Ph.D.
Vice President & General Manager
Diagnostics
Acknowledged and agreed to:
CALBIOCHEM-NOVABIOCHEM CORPORATION
By: /s/ XXXXXXX X. XXXXXXXXXXXX
--------------------------------
Name: Xxxxxxx X. Xxxxxxxxxxxx
------------------------------
Date: January 27, 1997
------------------------------
